课题基金 / 基金详情

Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques

Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques
用于恒河猴药物测定或重复、低剂量攻击研究的相关猿猴免疫缺陷病毒 (SIV) 库存的扩展和表征
批准号：
10551010
负责人：
PETER SILVERA
金额：
$8.36万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
项目状态：
已结题
起止时间：
2018-07-16 至 2022-01-31
来源：
https://reporter.nih.gov/project-details/10551010
关键词：
Animal ModelBiological AssayCollaborationsContractorContractsDoseHIVIn VitroInvestigator-Initiated ResearchMacaca mulattaNational Institute of Allergy and Infectious DiseaseNucleosidesPharmaceutical PreparationsPreventionRNA-Directed DNA PolymeraseResourcesSIVServicesTitrationsVaginaVirusVirus Diseasesin vivoinhibitormicrobicidepre-clinicalproduct developmentresearch study

项目摘要

项目成果

PETER SILVERA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Comprehensive Resources for Microbicides and Biomedical Prevention contract is to provide the NIAID with a comprehensive suite of preclinical product development services for candidate products that emerge from investigator-initiated research studies or from collaborations with outside companies or organizations. The Contractor shall provide: 1) Preclinical gap-filling services; 2) HIV animal models supporting product development; 3) Bioanalytical support services; 4) Product manufacturing; and 5) Scientific and quality/regulatory support services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
Expertise in Development of Pediatric Drug Formulations
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services
海外基金